Susquehanna International Group
ELOX

Susquehanna International Group’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Susquehanna International Group’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-297
Closed -$4.1K – 14439
2022
Q1 		$7K Sell
297
-569
-66% -$11.2K ﹤0.01% 12797
2021
Q4 		$25K Sell
866
-260
-23% -$11.3K ﹤0.01% 12789
2021
Q3 		$73K Buy
1,126
+357
+46% +$22K ﹤0.01% 12210
2021
Q2 		$61K Buy
+769
New +$64.2K ﹤0.01% 12253
2021
Q1 		– Sell
-337
Closed -$54K – 13055
2020
Q4 		$54K Buy
+337
New +$41.2K ﹤0.01% 10734
2020
Q1 		– Sell
-373
Closed -$110K – 11129
2019
Q4 		$110K Buy
373
+83
+29% +$16.7K ﹤0.01% 9103
2019
Q3 		$52K Buy
+290
New +$82.5K ﹤0.01% 9768

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Susquehanna International Group's ELOX Position: Q2 2022 in Review

Susquehanna International Group sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2022, closing a stake of 297 shares — an estimated $4.1K sold.

Susquehanna International Group first reported a position in ELOX in Q3 2019 and held it in 7 quarters. The position peaked at $110K in Q4 2019. 30 funds tracked by Wall St. Rank hold ELOX as of Q2 2022.

  • Susquehanna International Group reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Susquehanna International Group sold 297 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $4.1K.
  • Susquehanna International Group first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 7 quarters.
  • Susquehanna International Group's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $110K in Q4 2019.
  • 30 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.